Wake up daily to our latest coverage of business done better, directly in your inbox.
Get your weekly dose of analysis on rising corporate activism.
The best of solutions journalism in the sustainability space, published monthly.
Select Newsletter
By signing up you agree to our privacy policy. You can opt out anytime.
Pharma companies are failing to adequately disclose the impacts of their social contributions according to a new index.
The VV-Good index compares the Top 10 pharmaceutical companies according to their social, environmental and financial performance. For example Germany’s Merck scores 28% for its social impacts – a figure that reflects levels of disclosure as well as actual social performance. Next in line are Novartis (18%), AstraZeneca (15%) and Bayer (13%).
The overall impact score shows the performance of each company across all the indicators between 2010 and 2011 as a percentage. For example, have they screened more suppliers for human rights adherence or have they reduced their carbon dioxide emissions.
TriplePundit has published articles from over 1000 contributors. If you'd like to be a guest author, please get in touch!
